We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cardiac MRI Identifies Myocarditis in COVID-19 Recovering Athletes

By MedImaging International staff writers
Posted on 22 Sep 2020
Print article
A new study suggests that cardiac magnetic resonance (CMR) can help determine when athletes who have recovered from COVID-19 can safely return to play in competitive sports.

Researchers at Ohio State University (OSU, Columbus, USA) conducted a CMR imaging study in 26 college athletes (mean age, 19.5 years, 57.7% male) who tested positive for COVID-19 between June and August 2020, and following quarantine. The CMR examination included cine, T1 and T2 mapping, extracellular volume fraction, and late gadolinium enhancement (LGE). In addition, an electrocardiogram (ECG), serum troponin I, and transthoracic echocardiogram were performed on day of CMR imaging.

Overall, 12 of the athletes (26.9%) reported mild symptoms during the short-term infection period (sore throat, shortness of breath, myalgias, fever), while others were asymptomatic. There were no diagnostic ST/T wave changes on ECG, and ventricular volumes and function were within the normal range in all of the athletes, as shown by transthoracic echocardiogram and CMR imaging. No athlete showed elevated serum levels of troponin I.

The results showed four athletes (15%; all male) had CMR findings consistent with myocarditis, based on the presence of two main features of the updated Lake Louise Criteria: myocardial edema by elevated T2 signal and myocardial injury by presence of nonischemic LGE. Pericardial effusion was present in two of the athletes with CMR evidence of myocarditis. Mean T2 in those with suspected myocarditis was 59 milliseconds, compared to 51 milliseconds in those without CMR evidence of myocarditis. The study was published on September 11, 2020, in JAMA Cardiology.

“CMR has the potential to identify a high-risk group for adverse outcomes and may, importantly, risk stratify athletes for safe participation, as CMR mapping techniques have a high negative predictive value to rule out myocarditis,” said lead author cardiologist Saurabh Rajpal, MD. “Additionally, the CMR imaging ruled out myocarditis for all athletes without MRI evidence of inflammation, allowing them to return to playing sports.”

Myocarditis is an inflammation of the cardiac muscle which enlarges and weakens the heart, creates scar tissue, and forces it to work harder to circulate blood and oxygen throughout the body. Viral infections are a leading cause of myocarditis, with inflammation occurring during the course of infection, putting stress on the heart that remains even after the infection is resolved.

Related Links:
Ohio State University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
Compact C-Arm with FPD
Arcovis DRF-C R21
New
DR Flat Panel Detector
1500L

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.